Precigen

Precigen(PGEN)

GERMANTOWN, MD
Biotechnology

Focus: Cell & Gene Therapy

Precigen is a life sciences company focused on Cell & Gene Therapy.

Gene Therapy
Funding Stage
PUBLIC
Open Jobs
10

Pipeline & Clinical Trials

PRGN-3006 T Cells
Acute Myeloid Leukemia
Phase 1
Clinical Trials (1)
NCT03927261PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
Phase 1
Clinical Trials (1)
NCT05694364Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
Phase 1
Phase 1
Clinical Trials (1)
NCT03907527Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 1
INXN-4001
Heart Failure
Phase 1
Clinical Trials (1)
NCT03409627Novel INXN-4001 Triple Effector Plasmid in Heart Failure
Phase 1
AG019 - Low Dose
Diabetes type1
Phase 1/2
Clinical Trials (1)
NCT03751007A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)
Phase 1/2
PRGN-2012 - Phase I; Dose Level 1
Recurrent Respiratory Papillomatosis
Phase 1/2
Clinical Trials (1)
NCT04724980Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
Phase 1/2
PRGN-2009 plus Pembrolizumab
Cervical Cancer
Phase 2
Clinical Trials (1)
NCT06157151PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Phase 2
Phase 4
Clinical Trials (1)
NCT06538480Zopa Retreatment and Vector Shedding in Adults With RRP
Phase 4

Open Jobs (10)

Interview Prep Quick Facts
Founded: 2011
Portfolio: 8 clinical trials
Top TAs: Oncology, Respiratory, Metabolic Diseases
SEC Filings: 2 available
Open Roles: 10 active jobs
Therapeutic Area Focus
Oncology
3 pipeline
Respiratory
2 pipeline
Marketed
Pipeline

Financials (FY2024)

Net Income
$28M
Cash
$8M

Hiring Trend

Stable
10
Open Roles
+1
Added
-3
Filled/Removed

Based on last 4 crawl cycles